ChipMOS posts highest profit since 2022, revenue up 30% in 10 months

ChipMOS's 48% QoQ profit jump and 30% ten-month revenue growth are not a simple memory-cycle bounce. They signal a structural reallocation of profit toward test and packaging capacity, driven by AI's insatiable demand for HBM and advanced interconnect. The HBM3E-to-HBM4 transition multiplies test complexity: more stacking layers mean longer per-die test cycles and tighter yield control. ChipMOS's margin elasticity comes precisely from this "complexity premium" — customers pay more per unit, and test capacity expansion (18–24 months) is far faster than wafer-fab construction, making it the most elastic node in the AI memory stack. On competition, ASE locks in volume with Samsung and SK Hynix through scale, while Amkor captures geopolitical tailwinds via US-based capacity. ChipMOS's window is speed: winning second-tier memory customers during the HBM4 qualification cycle. But once 2027 capacity floods the market, test pricing will compress rapidly. Geopolitically, tightening US export controls on advanced memory to China paradoxically redirects test volume toward Taiwan, China nodes. However, over-concentration in a single customer or region will surface compliance and order-volatility risks within 12 months. Verdict: memory test remains the highest-conviction semiconductor subsector for the next two quarters. ChipMOS's valuation ceiling hinges on locking in HBM4-qualified customers before the window closes. Miss it, and 2027's capacity glut erases this earnings cycle.